Hypertrophy

Citations 91-100 of 489 total displayed.

Past content (since Jan 1999):

Vascular Medicine
Systemic Lupus Erythematosus Predicts Increased Left Ventricular Mass: Janice Pieretti, Mary J. Roman, Richard B. Devereux, Michael D. Lockshin, Mary K. Crow, Stephen A. Paget, Joseph E. Schwartz, Lisa Sammaritano, Daniel M. Levine, and Jane E. Salmon
Circulation 2007;116:419-426; published online before print as doi:10.1161/CIRCULATIONAHA.106.673319 [Abstract] [Full text]

Articles
Gi ${alpha}$ 1-Mediated Cardiac Electrophysiological Remodeling and Arrhythmia in Hypertrophic Cardiomyopathy: Hongmei Ruan, Scherise Mitchell, Monika Vainoriene, Qing Lou, Lai-Hua Xie, Shuxun Ren, Joshua I. Goldhaber, and Yibin Wang
Circulation published July 23, 2007, doi:10.1161/CIRCULATIONAHA.106.682773 [Abstract]

Editorials
Hypertrophied Right Hearts Get Two for the Price of One: Can Inhibiting Phosphodiesterase Type 5 Also Inhibit Phosphodiesterase Type 3?: David A. Kass
Circulation 2007;116:233-235, doi:10.1161/CIRCULATIONAHA.107.710988 [Full text]

Heart Failure
Phosphodiesterase Type 5 Is Highly Expressed in the Hypertrophied Human Right Ventricle, and Acute Inhibition of Phosphodiesterase Type 5 Improves Contractility: Jayan Nagendran, Stephen L. Archer, Daniel Soliman, Vikram Gurtu, Rohit Moudgil, Alois Haromy, Chantal St. Aubin, Linda Webster, Ivan M. Rebeyka, David B. Ross, Peter E. Light, Jason R.B. Dyck, and Evangelos D. Michelakis
Circulation 2007;116:238-248; published online before print as doi:10.1161/CIRCULATIONAHA.106.655266 [Abstract] [Full text]

Controversies in Cardiovascular Medicine
Surgical Myectomy Remains the Primary Treatment Option for Severely Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy: Barry J. Maron
Circulation 2007;116:196-206, doi:10.1161/CIRCULATIONAHA.107.691378 [Full text]

Controversies in Cardiovascular Medicine
Most Fully Informed Patients Choose Septal Ablation Over Septal Myectomy: Michael A. Fifer
Circulation 2007;116:207-216, doi:10.1161/CIRCULATIONAHA.107.688135 [Full text]

Articles
Systemic Lupus Erythematosus Predicts Increased Left Ventricular Mass: Janice Pieretti, Mary J. Roman, Richard B. Devereux, Michael D. Lockshin, Mary K. Crow, Stephen A. Paget, Joseph E. Schwartz, Lisa Sammaritano, Daniel M. Levine, and Jane E. Salmon
Circulation published July 9, 2007, doi:10.1161/CIRCULATIONAHA.106.673319 [Abstract]

Articles
Phosphodiesterase Type 5 Is Highly Expressed in the Hypertrophied Human Right Ventricle, and Acute Inhibition of Phosphodiesterase Type 5 Improves Contractility: Jayan Nagendran, Stephen L. Archer, Daniel Soliman, Vikram Gurtu, Rohit Moudgil, Alois Haromy, Chantal St. Aubin, Linda Webster, Ivan M. Rebeyka, David B. Ross, Peter E. Light, Jason R.B. Dyck, and Evangelos D. Michelakis
Circulation published July 2, 2007, doi:10.1161/CIRCULATIONAHA.106.655266 [Abstract]

Correspondence
Letter by Geier et al Regarding Article, "Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction": Christian Geier, Andreas Perrot, and Cemil Özcelik
Circulation 2007;115:e622, doi:10.1161/CIRCULATIONAHA.107.690057 [Full text]

Images in Cardiovascular Medicine
Myocardial Delayed Enhancement by Computed Tomography in Hypertrophic Cardiomyopathy: Afonso Akio Shiozaki, Tiago Senra Garcia Santos, Edmundo Artega, and Carlos Eduardo Rochitte
Circulation 2007;115:e430-431e, doi:10.1161/CIRCULATIONAHA.106.674911 [Full text]

Subspecialty Collections Home

Show Hypertrophy
collections from other journals.